ロード中...
The neoepitope landscape of breast cancer: implications for immunotherapy
BACKGROUND: Cancer immunotherapy with immune checkpoint blockade (CKB) is now standard of care for multiple cancers. The clinical response to CKB is associated with T cell immunity targeting cancer-induced mutations that generate novel HLA-binding epitopes (neoepitopes). METHODS: Here, we developed...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399957/ https://ncbi.nlm.nih.gov/pubmed/30832597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5402-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|